Milena Acencio Selected Research

N-Tyr- delta sleep-inducing peptide (ID-2)

1/2016

Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Milena Acencio Research Topics

Disease

1	Adenocarcinoma of Lung 01/2016
1	Carcinogenesis 01/2016

Drug/Important Bio-Agent (IBA)

1	N-Tyr- delta sleep-inducing peptide (ID-2)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016

Therapy/Procedure

1	Adjuvant Chemotherapy 01/2016